Triall

About:

End-to-end SaaS platform of blockchain-integrated software solutions for clinical trials.

Website: https://www.triall.io

Twitter/X: triallofficial

Top Investors: Zokyo

Description:

Triall brings Web3 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that secure and streamline clinical trials. Triall’s solutions make clinical trials tamper-resistant and enable secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes. Triall’s software is co-created with clinical trial professionals to ensure optimal user experience, solving actual industry pain points.

Total Funding Amount:

$2.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Maarssen, Utrecht, The Netherlands

Founded Date:

2018-05-07

Contact Email:

contact(AT)triall.io

Founders:

Hadil Es-Sbai, Joost Flach, Linda van de Burgwal, Mark van der Waal, Raymond van der Waal, Rob Posthumus

Number of Employees:

11-50

Last Funding Date:

2021-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai